Type of jaundice in neonates
Reading File
Now let me search the medical library for neonatal jaundice content in parallel.
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have rich content from multiple authoritative textbooks. Here is a thorough answer:
Types of Jaundice in Neonates
Neonatal jaundice (neonatal hyperbilirubinemia) is classified primarily by the type of bilirubin elevated (unconjugated/indirect vs. conjugated/direct) and then by etiology.
Broad Classification
| Type | Bilirubin | Nature |
|---|---|---|
| Unconjugated (indirect) hyperbilirubinemia | Indirect | Usually benign/physiologic, but can be pathologic |
| Conjugated (direct) hyperbilirubinemia | Direct | Always pathologic |
Three physiologic factors contribute to neonatal unconjugated jaundice: (1) increased bilirubin production, (2) decreased clearance/excretion, and (3) increased enterohepatic resorption. - Rosen's Emergency Medicine
A. Unconjugated (Indirect) Hyperbilirubinemia
1. Physiologic Jaundice of the Newborn
- Most common type - affects ~50% of normal newborns
- Due to immature hepatic glucuronosyltransferase + accelerated red cell turnover
- Onset: Day 2-3 of life (never in the first 24 hours)
- Peak: Day 4-5 (rarely exceeds 12-15 mg/dL in term infants)
- Resolution: Within 2 weeks in term infants (longer in preterm)
- Rises at a rate no more than 5 mg/dL/day
- Requires no treatment in most cases; phototherapy if rising
2. Breast Milk Jaundice
- Second most common cause
- Pathophysiology uncertain - may be hormonally mediated or related to increased enterohepatic resorption, or bilirubin-deconjugating enzymes in breast milk
- Peaks later than physiologic jaundice (around 10-21 days of life)
- May persist for 3-10 weeks
- Mild unconjugated hyperbilirubinemia; generally benign
3. Hemolytic Causes
- Hemolytic Disease of the Fetus & Newborn (HDFN): ABO or Rh incompatibility - most common cause of severe hyperbilirubinemia
- Physiologic breakdown of fetal hemoglobin
- Hemoglobinopathies (e.g., sickle cell)
- Inherited RBC membrane defects (e.g., hereditary spherocytosis)
- Enzyme defects (e.g., G6PD deficiency)
- Sepsis
4. Polycythemia
- Excess RBC mass leads to increased bilirubin production from hemoglobin breakdown
5. Increased Enterohepatic Circulation
- Hirschsprung disease, cystic fibrosis, biliary atresia (delayed passage of meconium delays bilirubin excretion)
6. Inherited Disorders of Bilirubin Metabolism
| Disorder | Key Feature |
|---|---|
| Gilbert syndrome | Mildly reduced glucuronosyltransferase; autosomal recessive; benign, fluctuating unconjugated hyperbilirubinemia |
| Crigler-Najjar Type I | Complete absence of UDP-glucuronosyltransferase; severe jaundice >20 mg/dL; fatal in infancy if untreated |
| Crigler-Najjar Type II | Partial enzyme deficiency; serum bilirubin usually <20 mg/dL; responds to phenobarbital |
B. Conjugated (Direct) Hyperbilirubinemia
Conjugated hyperbilirubinemia in neonates is always pathologic. - Rosen's Emergency Medicine
| Category | Specific Causes |
|---|---|
| Biliary obstruction | Extrahepatic biliary atresia (most common surgical cause) |
| Infection | Sepsis, TORCH infections (toxoplasmosis, rubella, CMV, herpes, syphilis) |
| Neonatal hepatitis | Idiopathic, Wilson disease, alpha-1 antitrypsin deficiency |
| Metabolic disorders | Galactosemia, hereditary fructose intolerance, glycogen storage disease |
| Inherited transport defects | Dubin-Johnson syndrome (dark pigmented liver), Rotor syndrome |
| Parenteral alimentation | TPN-associated cholestasis |
Key Danger: Kernicterus (Bilirubin Encephalopathy)
When unconjugated bilirubin exceeds the albumin-binding capacity (generally at levels >20-25 mg/dL), it crosses the blood-brain barrier and causes neuronal death - termed kernicterus (chronic) or bilirubin-induced neurologic dysfunction (BIND) (acute).
Acute symptoms: Poor feeding, lethargy, high-pitched cry, opisthotonos, seizures
Chronic sequelae: Cerebral palsy, sensorineural hearing loss, gaze abnormalities, intellectual disability
Chronic sequelae: Cerebral palsy, sensorineural hearing loss, gaze abnormalities, intellectual disability
Risk Factors for Severe Hyperbilirubinemia
- Prematurity
- Isoimmune hemolysis (ABO, Rh incompatibility)
- Sepsis
- Cephalhematoma
- Dehydration
- G6PD deficiency, hereditary spherocytosis
Treatment Approach
- Phototherapy (blue light): First-line for unconjugated hyperbilirubinemia; converts bilirubin to a water-soluble isomer excreted in urine
- Phenobarbital: Induces bilirubin metabolism (used in Crigler-Najjar Type II)
- Exchange transfusion: For severe/refractory cases with rising bilirubin near toxic levels
Sources: Rosen's Emergency Medicine, Robbins & Kumar Basic Pathology, Harper's Illustrated Biochemistry (32nd Ed), Quick Compendium of Clinical Pathology (5th Ed), Medical Physiology
This is a shared conversation. Sign in to Orris to start your own chat.